LANCL2 Activators

Chemical activators of LANCL2, or LanC Like 2, primarily operate through key pathways that are known to modulate LANCL2 expression and function, such as the AMPK pathway, PPARγ pathway, and cAMP pathway. Several of the selected compounds, including Metformin, AICAR, Rosiglitazone, Pioglitazone, Forskolin, and DDA, act as activators within these pathways. They can lead to increased expression of LANCL2 by activating AMPK, PPARγ, or by increasing cAMP levels, which have been associated with LANCL2 modulation.

Additional compounds, such as H-89, KT5720, IBMX, SQ22536, KH7, and MDL12330A, can also influence LANCL2 activity but do so by inhibiting certain elements of these pathways. By inhibiting PKA, a downstream signal of cAMP, or by directly inhibiting adenylate cyclase and decreasing cAMP levels, these compounds can potentially modulate LANCL2 activity. Collectively, these chemicals provide an array of potential influence points on LANCL2 through their varied mechanisms of action.